
JPXHealthcareMedical - Instruments & Supplies
Latest quote
¥457
+¥2.00 · +0.44%
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
Latest quote
¥457
+¥2.00 · +0.44%
Regular session · JST · Market data may be delayed.
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
Day range
Current ¥457
52-week range
Current ¥457
Regular session · JST · Market data may be delayed.
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
Day range
Current ¥457
52-week range
Current ¥457
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 65.85B JPY | 69.75B JPY | 65.29B JPY | 63.74B JPY | 58.17B JPY |
| Cost of goods sold | 50.49B JPY | 53.82B JPY | 51.2B JPY | 49.15B JPY | 43.9B JPY |
| Gross profit | 15.36B JPY | 15.93B JPY | 14.09B JPY | 14.6B JPY | 14.27B JPY |
| Research and development | — | — | 1.52B JPY | 1.32B JPY | 1.53B JPY |
| Selling, general, and administrative | 14.97B JPY | 15.05B JPY | 12.45B JPY | 12.12B JPY | 11.37B JPY |
| Operating expenses | 14.97B JPY | 15.05B JPY | 14.36B JPY | 13.87B JPY | 13.29B JPY |
| Interest income | 31M JPY | 19M JPY | 14M JPY | 12M JPY | 7M JPY |
| Interest expense | 407M JPY | 340M JPY | 220M JPY | 167M JPY | 159M JPY |
| Depreciation and amortization | 3.83B JPY | 3.89B JPY | 3.71B JPY | 3.59B JPY | 3.36B JPY |
| Operating income | 383M JPY | 874M JPY | −268M JPY | 724M JPY | 980M JPY |
| Net income | −784M JPY | 89M JPY | −36M JPY | 281M JPY | 826M JPY |
Company facts updated Sep 7, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥17.00
2025 complete year0.0% since 2021
2026 partial: ¥8.50
¥17.00
2,021
¥17.00
2,022
¥17.00
2,023
¥17.00
2,024
¥17.00
2,025
¥8.50
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥8.50Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 30, 2027 | ¥8.50Semi-Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥8.50Semi-Annual | Mar 31, 2026 | Jun 24, 2026 |
Dividend | Sep 29, 2025 | ¥8.50Semi-Annual | Sep 30, 2025 | Dec 10, 2025 |
Dividend | Mar 28, 2025 | ¥8.50Semi-Annual | Mar 31, 2025 | Jun 25, 2025 |
Dividend | Sep 27, 2024 | ¥8.50Semi-Annual | Sep 30, 2024 | Dec 10, 2024 |
Ex-dividend Sep 29, 2026
¥8.50
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2027
¥8.50
Semi-Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥8.50
Semi-Annual
Record Mar 31, 2026 · Payment Jun 24, 2026
Ex-dividend Sep 29, 2025
¥8.50
Semi-Annual
Record Sep 30, 2025 · Payment Dec 10, 2025
Ex-dividend Mar 28, 2025
¥8.50
Semi-Annual
Record Mar 31, 2025 · Payment Jun 25, 2025
Ex-dividend Sep 27, 2024
¥8.50
Semi-Annual
Record Sep 30, 2024 · Payment Dec 10, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T24.52M0.00%2.92T JPY0.05%¥423.6+0.47%
Dimensional - International Small Cap Value ETFDISV55.08K0.00%5.41B USD0.42%$44.98+0.04%
Dimensional - International Core Equity 2 ETFDFIC51.13K0.00%15.56B USD0.22%$39.475-0.01%
Dimensional World ex U.S. Core Equity 2 ETFDFAX29.72K0.00%12.71B USD0.28%$38.61+0.44%
Dimensional - International Small Cap ETFDFIS9.33K0.00%6.05B USD0.39%$37.67+0.13%
iShares Core TOPIX ETF1475.T
Dimensional - International Small Cap Value ETFDISV
Dimensional - International Core Equity 2 ETFDFIC
Dimensional World ex U.S. Core Equity 2 ETFDFAX
Dimensional - International Small Cap ETFDFISAI-generated and delayed market data for informational and educational purposes only. Not investment advice.